Cargando…
Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
Background and aims: Favipiravir is a ribonucleic acid (RNA)-dependent RNA polymerase (RdRP) inhibitor antiviral agent used in the treatment of coronavirus disease-2019 (COVID-19). In this study, we investigated the changes in serum transaminase levels of patients and the relationship between serum...
Autores principales: | Bayram, Mehmet, Yildirim, Ozgur, Ozmen, Raye Sevra, Soylu, Beyza, Dundar, Ahmet Said, Koksal, Ali Riza, Akarsu, Murat, Kumbasar, Abdulbaki, Tabak, Omur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530246/ https://www.ncbi.nlm.nih.gov/pubmed/34703696 http://dx.doi.org/10.7759/cureus.18166 |
Ejemplares similares
-
Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19
por: Bayram, Mehmet, et al.
Publicado: (2021) -
Favipiravir: Erythema and transaminase elevation: case report
Publicado: (2022) -
Selective Attention and Information Processing Speed in Graves’ Disease: Stroop Interference Effect
por: Ekinci, İskender, et al.
Publicado: (2021) -
A Rise in Aspartate Transaminase and Alanine Transaminase Associated With Ondansetron Administration in a Pregnant Female
por: Couse, Michael, et al.
Publicado: (2020) -
Plasma Zonulin Levels as a Non-Invasive Biomarker of Intestinal Permeability in Women with Gestational Diabetes Mellitus
por: Demir, Esra, et al.
Publicado: (2019)